CTNNB1 S45F Mutation Predicts Poor Efficacy of Meloxicam Treatment for Desmoid Tumors: A Pilot Study

Shunsuke Hamada, Naohisa Futamura, K. Ikuta, +4

PLoS ONE

PathologyCancer BiologyTumor BiologyPilot StudyCancer Cell Biology +14

Factors predicting the therapeutic response to infliximab during maintenance therapy in Japanese patients with Crohn’s disease

Katsuyoshi Matsuoka, Shunsuke Hamada, Mikiko Shimizu, +12

PLoS ONE

Chronic Inflammatory DiseasesImmunologyGastroenterologyTherapeutic ResponseInflammatory Arthritis +16

Heat-stimuli-enhanced osteogenesis using clinically available biomaterials

Takehiro Ota, Yoshihiro Nishida, K. Ikuta, +5

PLoS ONE

Tissue EngineeringEngineeringAlginate GelBone RepairVivo Rat Model +18

Expression of colony-stimulating factor 1 is associated with occurrence of osteochondral change in pigmented villonodular synovitis

Takehiro Ota, Hiroshi Urakawa, Eiji Kozawa, +6

Tumor Biology

Is immunohistochemical staining for β-catenin the definitive pathological diagnostic tool for desmoid-type fibromatosis? A multi-institutional study

Hiroshi Koike, Yoshihiro Nishida, Kei Kohno, +14

Human Pathology

FibrosisMedicineSurgical PathologyHistopathologyDiagnosis +9

Phase <scp>II</scp> clinical trial of pazopanib for patients with unresectable or metastatic malignant peripheral nerve sheath tumors

Yoshihiro Nishida, Hiroshi Urakawa, Robert Nakayama, +15

International Journal of Cancer

Neuro-oncologySurgical OncologyPazopanib TreatmentTumor InnervationGlioma +12

Analysis of Factors for Predicting Survival in Soft-tissue Sarcoma with Metastatic Disease at Initial Presentation

Tomoki Nakamura, Hirohisa Katagiri, Yoji Shido, +9

Anticancer Research

Low-dose chemotherapy with methotrexate and vinblastine for patients with desmoid tumors: relationship to CTNNB1 mutation status

Yoshihiro Nishida, Satoshi Tsukushi, Hiroshi Urakawa, +4

International Journal of Clinical Oncology

Tumor BiologyMedicinePathologyLow-dose ChemotherapyCtnnb1 Mutation Status +6

Antitumor effects of 4‐methylumbelliferone, a hyaluronan synthesis inhibitor, on malignant peripheral nerve sheath tumor

K. Ikuta, Takehiro Ota, Lisheng Zhuo, +6

International Journal of Cancer

Hyaluronan Synthesis InhibitorMalignant DiseaseMedicineTumor GrowthPharmacology +12

Desmoid with biweekly methotrexate and vinblastine shows similar effects to weekly administration: A phase II clinical trial

Yoshihiro Nishida, Shunsuke Hamada, Hiroshi Urakawa, +7

Cancer Science